Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
11,729 Dovepress* 5,333 2,105+ 1,085 7,438
PubMed Central* 0 4,291 802 4,291
Totals 5,333 6,396 1,887 11,729
*Since 14 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 1 0 0 4 9

View citations on PubMed Central and Google Scholar